Skip to main content
Caplight Logo









Libero Pharma

Libero Pharma

Private
EdinburghHealthcare & Life Scienceshttps://liberopharma.com/

Last Round

VC Round

Jun 2, 2026

Total Funding Raised

$3.16M

Company Overview

Libero Pharma is a biotechnology company that develops transdermal naltrexone patch delivery systems for the management of opioid use disorder, alcohol use disorder, and other chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

transdermal drug deliverynaltrexone patchdrug repurposingbiotechnologyCNS disorderscentral nervous systemdrug delivery systemsaddiction treatmentformulation developmentclinical developmentpatch technologypharma R&Dsustained releasedrug delivery techbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Libero Pharma Comparables

Compare Libero Pharma with similar companies based on industry and business-model similarity.

Libero Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medherant Limited
82%
Alkermes plc
62%
Corium Innovations
61%

Libero Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 2, 2026
VC RoundNov 15, 2022
GrantSep 20, 2022
VC RoundMay 10, 2021
VC RoundApr 29, 2019

Libero Pharma Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2019

    $320K raised from Highland Venture Capital and others.

Libero Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Libero Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Libero Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range5
Year Founded2018
Last FundingJun 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?